Mark Kellett

3.6k total citations
30 papers, 898 citations indexed

About

Mark Kellett is a scholar working on Neurology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Mark Kellett has authored 30 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Epidemiology. Recurrent topics in Mark Kellett's work include Neurological disorders and treatments (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neurofibromatosis and Schwannoma Cases (6 papers). Mark Kellett is often cited by papers focused on Neurological disorders and treatments (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Neurofibromatosis and Schwannoma Cases (6 papers). Mark Kellett collaborates with scholars based in United Kingdom, Australia and United States. Mark Kellett's co-authors include David Chadwick, Stephen W. McKechnie, Ary A. Hoffmann, Gus A. Baker, David F. Smith, Alan R. Crossman, Susan H. Fox, Jonathan M. Brotchie, Nicholas Fletcher and Austen Peter Moore and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

Mark Kellett

30 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kellett United Kingdom 16 289 276 245 185 133 30 898
P. Lamberti Italy 22 648 2.2× 194 0.7× 241 1.0× 24 0.1× 97 0.7× 49 1.2k
David E. Mandelbaum United States 20 187 0.6× 397 1.4× 687 2.8× 386 2.1× 40 0.3× 39 1.5k
Maria Mazurkiewicz‐Bełdzińska Poland 19 69 0.2× 356 1.3× 570 2.3× 408 2.2× 242 1.8× 83 1.5k
Jinane Fattouch Italy 17 139 0.5× 247 0.9× 630 2.6× 383 2.1× 18 0.1× 56 861
John M. Schreiber United States 18 90 0.3× 226 0.8× 396 1.6× 182 1.0× 67 0.5× 37 963
Hanne Gredal Denmark 14 48 0.2× 146 0.5× 306 1.2× 195 1.1× 13 0.1× 29 686
Jayne Antony Australia 20 303 1.0× 205 0.7× 345 1.4× 126 0.7× 7 0.1× 40 982
A Mangoni Italy 16 342 1.2× 223 0.8× 98 0.4× 37 0.2× 18 0.1× 48 819
Mark Agostini United States 13 418 1.4× 203 0.7× 432 1.8× 215 1.2× 6 0.0× 27 851
Manfred Oehmichen Germany 23 290 1.0× 202 0.7× 20 0.1× 148 0.8× 23 0.2× 50 1.3k

Countries citing papers authored by Mark Kellett

Since Specialization
Citations

This map shows the geographic impact of Mark Kellett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kellett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kellett more than expected).

Fields of papers citing papers by Mark Kellett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kellett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kellett. The network helps show where Mark Kellett may publish in the future.

Co-authorship network of co-authors of Mark Kellett

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kellett. A scholar is included among the top collaborators of Mark Kellett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kellett. Mark Kellett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moualed, Daniel, Jonathan Wong, Owen Thomas, et al.. (2022). Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variants. European Journal of Human Genetics. 30(4). 458–464. 8 indexed citations
2.
King, Andrew T., Scott Rutherford, Charlotte Hammerbeck-Ward, et al.. (2017). Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated Patient. Neurosurgery. 83(1). 38–42. 20 indexed citations
3.
Kalamarides, Michel, Walid Ibn Essayed, Jean‐Paul Lejeune, et al.. (2017). Spinal ependymomas in NF2: a surgical disease?. Journal of Neuro-Oncology. 136(3). 605–611. 19 indexed citations
4.
Kobylecki, Christopher, David J. Burn, Lewis Kass‐Iliyya, et al.. (2014). Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease. Parkinsonism & Related Disorders. 20(4). 452–455. 35 indexed citations
5.
Michou, Emilia, Shaheen Hamdy, Mary L. Harris, et al.. (2014). Characterization of Corticobulbar Pharyngeal Neurophysiology in Dysphagic Patients With Parkinson's Disease. Clinical Gastroenterology and Hepatology. 12(12). 2037–2045.e4. 24 indexed citations
6.
Poliakoff, Ellen, Adam Galpin, Kathryn McDonald, et al.. (2013). The effect of gym training on multiple outcomes in Parkinson's disease: A pilot randomised waiting-list controlled trial. Neurorehabilitation. 32(1). 125–134. 29 indexed citations
7.
Kobylecki, Christopher, Andrew Marshall, David Gosal, Monty Silverdale, & Mark Kellett. (2012). 114 Subacute axonal and demyelinating peripheral neuropathy complicating Duodopa therapy for Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. 83(3). e1.64–e1. 1 indexed citations
8.
Gow, David Lee, et al.. (2011). Itraconazole associated quadriparesis and edema: a case report. Journal of Medical Case Reports. 5(1). 140–140. 5 indexed citations
9.
Chinnery, Patrick F., Douglas E. Crompton, D. Birchall, et al.. (2006). Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain. 130(1). 110–119. 134 indexed citations
10.
11.
Lozsádi, Dora A., Gerd Peters, Helen Sadik, et al.. (2005). Prevention of osteoporosis in glucocorticoid-treated neurology patients. Clinical Neurology and Neurosurgery. 108(2). 157–162. 10 indexed citations
12.
Kellett, Mark, Ary A. Hoffmann, & Stephen W. McKechnie. (2005). Hardening capacity in the Drosophila melanogaster species group is constrained by basal thermotolerance. Functional Ecology. 19(5). 853–858. 69 indexed citations
13.
Anderson, Alisha, Janelle E. Collinge, Ary A. Hoffmann, Mark Kellett, & Stephen W. McKechnie. (2003). Thermal tolerance trade-offs associated with the right arm of chromosome 3 and marked by the hsr-omega gene in Drosophila melanogaster. Heredity. 90(2). 195–202. 90 indexed citations
14.
Fox, Susan H., Monty Silverdale, Mark Kellett, et al.. (2003). Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease. Movement Disorders. 19(5). 554–560. 50 indexed citations
15.
Fox, Susan H., Mark Kellett, Austen Peter Moore, Alan R. Crossman, & Jonathan M. Brotchie. (2002). Randomised, double‐blind, placebo‐controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. Movement Disorders. 17(1). 145–149. 88 indexed citations
16.
Kellett, Mark, et al.. (1998). Hyperekplexia and trismus due to brainstem encephalopathy. Journal of Neurology Neurosurgery & Psychiatry. 65(1). 122–125. 19 indexed citations
17.
Kellett, Mark, Gavin Young, & Nicholas Fletcher. (1997). Painful tonic spasms and pure motor hemiparesis due to lacunar pontine infarct. Movement Disorders. 12(6). 1094–1096. 2 indexed citations
18.
Kellett, Mark, David F. Smith, Gus A. Baker, & David Chadwick. (1997). Quality of life after epilepsy surgery. Journal of Neurology Neurosurgery & Psychiatry. 63(1). 52–58. 125 indexed citations
19.
Kellett, Mark, Gavin Young, & Nicholas Fletcher. (1997). Paraparesis Due to Syphilitic Aortic Dissection. Neurology. 48(1). 221–223. 15 indexed citations
20.
Kellett, Mark, Nicholas Fletcher, Nicholas Wood, & T P Enevoldson. (1997). Trinucleotide (GAA)n repeat expansion in two families with Friedreich's ataxia with retained reflexes. Journal of Neurology Neurosurgery & Psychiatry. 63(6). 780–783. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Lamberti Breakdown of academic impact, for papers by David E. Mandelbaum Breakdown of academic impact, for papers by Maria Mazurkiewicz‐Bełdzińska Breakdown of academic impact, for papers by Jinane Fattouch Breakdown of academic impact, for papers by John M. Schreiber Breakdown of academic impact, for papers by Hanne Gredal Breakdown of academic impact, for papers by Jayne Antony Breakdown of academic impact, for papers by A Mangoni Breakdown of academic impact, for papers by Mark Agostini Breakdown of academic impact, for papers by Manfred Oehmichen
Rankless by CCL
2026